Hope Starkman
Rheumatology · Lake Worth, FLNPI 1144216797
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,447 of the $3,228 with a category attached, or 75.8%. 22 manufacturers reported payments, led by Johnson & Johnson at 26.9% of the total. Reporting peaked in 2021 at $1,146 and has fallen 98.6% since, to $16 in 2024. That places this record below the midpoint for rheumatology clinicians in FL, where the typical reported total is $6,335.
Across 119 payments — averaging $27.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$870
- AbbVie$560
- Pfizer$363
- UCB, Inc.$319
- Amgen$216
- Radius Health, Inc.$114
- plus $787 from 16 others
What the payments were for
- Consulting fees$52516%
- Grants$2407%
- Food & beverage$2,44776%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 15 | $870 |
| AbbVie | 14 | $560 |
| Pfizer | 19 | $363 |
| UCB, Inc. | 17 | $319 |
| Amgen | 11 | $216 |
| Radius Health, Inc. | 5 | $114 |
| Boehringer Ingelheim | 4 | $111 |
| Mallinckrodt Enterprises LLC | 5 | $92 |
| GSK | 3 | $81 |
| Lilly USA, LLC | 4 | $77 |
| ANI Pharmaceuticals, Inc. | 3 | $71 |
| Genentech USA, Inc. | 3 | $65 |
| AstraZeneca(2 entities) | 3 | $62 |
| Mallinckrodt Hospital Products Inc. | 2 | $44 |
| Novartis | 2 | $36 |
| Sanofi | 2 | $31 |
| Alvogen Inc | 1 | $30 |
| Zimmer Biomet | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Organon | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Fidia Pharma USA Inc. | 2 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELARA$525
- SIMPONI ARIA$525
- Tremfya$525
- Rinvoq$240
How this compares
$3,228 in reported general payments places this provider in the 35th percentile of 453 rheumatology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 21 | $761 |
| MethotrexateMethotrexate Sodium | 30 | $593 |
| Prednisone | 30 | $301 |
| Alendronate Sodium | 30 | $234 |
| Duloxetine Hcl | 12 | $137 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Lake Worth
- Juan Jose Maya VillamizarLake Worth$37K
- Alvin WellsDestin$2.4M
- Guillermo ValenzuelaPlantation$1.5M
- Julio Gonzalez-PaoliTampa$1.4M
- Ernesto RodriguezZephyrhills$958K
- Vinicius Costa Diniz DominguesDaytona Beach$921K
- Jonathan GreerBoynton Beach$757K
- Jigar ShahMargate$750K
- Rachel TateHollywood$729K
- Howard BuschLoxahatchee$717K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.